▶ 調査レポート

H2受容体拮抗薬のグローバル市場 2021年：企業別、地域別、種類・用途別
• 英文タイトル：Global H2-Receptor Antagonists Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

GlobalInfoResearchが調査・発行した産業分析レポートです。H2受容体拮抗薬のグローバル市場 2021年：企業別、地域別、種類・用途別 / Global H2-Receptor Antagonists Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026 / GIR-203B16199資料のイメージです。• レポートコード：GIR-203B16199
• 出版社/出版日：GlobalInfoResearch / 2021年12月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、153ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：医薬品
• 販売価格（消費税別）
  Single User￥522,000 (USD3,480)▷ お問い合わせ
  Multi User￥783,000 (USD5,220)▷ お問い合わせ
  Corporate User￥1,044,000 (USD6,960)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
H2受容体拮抗薬市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のH2受容体拮抗薬の市場規模は2020年のxxx米ドルから2021年にはxxx米ドルと推定され、2020年から2021年の間にxxx％の変化があります。世界のH2受容体拮抗薬の市場規模は次の5年間でxxx％のCAGRで成長すると予想されます。

H2受容体拮抗薬市場は種類と用途によって区分されます。2016年～2026年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・ラニチジン/ザンタック、シメチジン、ファモチジン、ナザチジン

用途別セグメントは次のように区分されます。
・小売店、クリニック、病院、OTC販売

世界のH2受容体拮抗薬市場の主要な市場プレーヤーは以下のとおりです。
・Acic Pharmaceuticals、Actavis Mid Atlantic LLC、Ajanta Pharma、AmerisourceBergen、Amneal Pharmaceuticals、ANDA Repository、Ani Pharmaceuticals、Apotex Inc. (and Apotex Corporation)、Appco Pharma、Aurobindo Pharma、Ben Venue Laboratories Inc.、Boehringer Ingelheim、Breckenridge Pharmaceuticals、Contract Pharmacal Corp.、Dr. Reddy's Laboratories Inc.、Geri-Care Pharmaceuticals、GlaxoSmithKline、Glenmark Pharmaceuticals、Granules Pharmaceuticals Inc.、Heritage Pharma Labs Inc.、Hikma Pharmaceuticals、Hi-Tech Pharmacal Co.、Lannett Co.、Mylan Pharmaceuticals Inc.、Nostrum Laboratories Inc.、Novitium Pharma、PAI Holdings, LLC、Par Pharmaceutical Inc.、Perrigo、Ranbaxy Inc.、Sandoz Inc.、Sanofi-Aventis、Strides、Sun Pharma、Taro Pharmaceuticals、Teva Pharmaceuticals、Thirty Madison、Torrent Pharma、Unique Pharmaceutical Laboratories、VKT Pharma

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計14章あります。
・第1章では、H2受容体拮抗薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なH2受容体拮抗薬メーカーの企業概要、2019年～2021年までのH2受容体拮抗薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なH2受容体拮抗薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2016年～2026年までの地域別H2受容体拮抗薬の販売量、売上、成長性を示しています。
・第5、6章では、2016年～2026年までのH2受容体拮抗薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2016年～2021年までの世界の主要国での販売量、売上、市場シェア、並びに2021年～2026年までの主要地域でのH2受容体拮抗薬市場予測を収録しています。
・第12、13、14章では、H2受容体拮抗薬の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Acic Pharmaceuticals、Actavis Mid Atlantic LLC、Ajanta Pharma、AmerisourceBergen、Amneal Pharmaceuticals、ANDA Repository、Ani Pharmaceuticals、Apotex Inc. (and Apotex Corporation)、Appco Pharma、Aurobindo Pharma、Ben Venue Laboratories Inc.、Boehringer Ingelheim、Breckenridge Pharmaceuticals、Contract Pharmacal Corp.、Dr. Reddy's Laboratories Inc.、Geri-Care Pharmaceuticals、GlaxoSmithKline、Glenmark Pharmaceuticals、Granules Pharmaceuticals Inc.、Heritage Pharma Labs Inc.、Hikma Pharmaceuticals、Hi-Tech Pharmacal Co.、Lannett Co.、Mylan Pharmaceuticals Inc.、Nostrum Laboratories Inc.、Novitium Pharma、PAI Holdings, LLC、Par Pharmaceutical Inc.、Perrigo、Ranbaxy Inc.、Sandoz Inc.、Sanofi-Aventis、Strides、Sun Pharma、Taro Pharmaceuticals、Teva Pharmaceuticals、Thirty Madison、Torrent Pharma、Unique Pharmaceutical Laboratories、VKT Pharma
・メーカー別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年：ラニチジン/ザンタック、シメチジン、ファモチジン、ナザチジン
・用途別分析2016年-2026年：小売店、クリニック、病院、OTC販売
・H2受容体拮抗薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ
・H2受容体拮抗薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア
・H2受容体拮抗薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア
・H2受容体拮抗薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン
・H2受容体拮抗薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The H2-Receptor Antagonists market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global H2-Receptor Antagonists size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global H2-Receptor Antagonists market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
H2-Receptor Antagonists market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Ranitidine/Zantac
Cimetidine
Famotidine
Nazatidine

Market segment by Application can be divided into
Retail Stores
Clinics
Hospitals
OTC Sales

The key market players for global H2-Receptor Antagonists market are listed below:
Acic Pharmaceuticals
Actavis Mid Atlantic LLC
Ajanta Pharma
AmerisourceBergen
Amneal Pharmaceuticals
ANDA Repository
Ani Pharmaceuticals
Apotex Inc. (and Apotex Corporation)
Appco Pharma
Aurobindo Pharma
Ben Venue Laboratories Inc.
Boehringer Ingelheim
Breckenridge Pharmaceuticals
Contract Pharmacal Corp.
Dr. Reddy’s Laboratories Inc.
Geri-Care Pharmaceuticals
GlaxoSmithKline
Glenmark Pharmaceuticals
Granules Pharmaceuticals Inc.
Heritage Pharma Labs Inc.
Hikma Pharmaceuticals
Hi-Tech Pharmacal Co.
Lannett Co.
Mylan Pharmaceuticals Inc.
Nostrum Laboratories Inc.
Novitium Pharma
PAI Holdings, LLC
Par Pharmaceutical Inc.
Perrigo
Ranbaxy Inc.
Sandoz Inc.
Sanofi-Aventis
Strides
Sun Pharma
Taro Pharmaceuticals
Teva Pharmaceuticals
Thirty Madison
Torrent Pharma
Unique Pharmaceutical Laboratories
VKT Pharma

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe H2-Receptor Antagonists product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of H2-Receptor Antagonists, with price, sales, revenue and global market share of H2-Receptor Antagonists in 2018 and 2019.
Chapter 3, the H2-Receptor Antagonists competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the H2-Receptor Antagonists breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and H2-Receptor Antagonists market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe H2-Receptor Antagonists sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

1 Market Overview
1.1 H2-Receptor Antagonists Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global H2-Receptor Antagonists Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Ranitidine/Zantac
1.2.3 Cimetidine
1.2.4 Famotidine
1.2.5 Nazatidine
1.3 Market Analysis by Application
1.3.1 Overview: Global H2-Receptor Antagonists Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Retail Stores
1.3.3 Clinics
1.3.4 Hospitals
1.3.5 OTC Sales
1.4 Global H2-Receptor Antagonists Market Size & Forecast
1.4.1 Global H2-Receptor Antagonists Sales in Value (2016-2026))
1.4.2 Global H2-Receptor Antagonists Sales in Volume (2016-2026)
1.4.3 Global H2-Receptor Antagonists Price by Type (2016-2026) & (US$/Unit)
1.5 Global H2-Receptor Antagonists Production Capacity Analysis
1.5.1 Global H2-Receptor Antagonists Total Production Capacity (2016-2026)
1.5.2 Global H2-Receptor Antagonists Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 H2-Receptor Antagonists Market Drivers
1.6.2 H2-Receptor Antagonists Market Restraints
1.6.3 H2-Receptor Antagonists Trends Analysis
2 Manufacturers Profiles
2.1 Acic Pharmaceuticals
2.1.1 Acic Pharmaceuticals Details
2.1.2 Acic Pharmaceuticals Major Business
2.1.3 Acic Pharmaceuticals H2-Receptor Antagonists Product and Services
2.1.4 Acic Pharmaceuticals H2-Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Actavis Mid Atlantic LLC
2.2.1 Actavis Mid Atlantic LLC Details
2.2.2 Actavis Mid Atlantic LLC Major Business
2.2.3 Actavis Mid Atlantic LLC H2-Receptor Antagonists Product and Services
2.2.4 Actavis Mid Atlantic LLC H2-Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Ajanta Pharma
2.3.1 Ajanta Pharma Details
2.3.2 Ajanta Pharma Major Business
2.3.3 Ajanta Pharma H2-Receptor Antagonists Product and Services
2.3.4 Ajanta Pharma H2-Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 AmerisourceBergen
2.4.1 AmerisourceBergen Details
2.4.2 AmerisourceBergen Major Business
2.4.3 AmerisourceBergen H2-Receptor Antagonists Product and Services
2.4.4 AmerisourceBergen H2-Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Amneal Pharmaceuticals
2.5.1 Amneal Pharmaceuticals Details
2.5.2 Amneal Pharmaceuticals Major Business
2.5.3 Amneal Pharmaceuticals H2-Receptor Antagonists Product and Services
2.5.4 Amneal Pharmaceuticals H2-Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 ANDA Repository
2.6.1 ANDA Repository Details
2.6.2 ANDA Repository Major Business
2.6.3 ANDA Repository H2-Receptor Antagonists Product and Services
2.6.4 ANDA Repository H2-Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Ani Pharmaceuticals
2.7.1 Ani Pharmaceuticals Details
2.7.2 Ani Pharmaceuticals Major Business
2.7.3 Ani Pharmaceuticals H2-Receptor Antagonists Product and Services
2.7.4 Ani Pharmaceuticals H2-Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Apotex Inc. (and Apotex Corporation)
2.8.1 Apotex Inc. (and Apotex Corporation) Details
2.8.2 Apotex Inc. (and Apotex Corporation) Major Business
2.8.3 Apotex Inc. (and Apotex Corporation) H2-Receptor Antagonists Product and Services
2.8.4 Apotex Inc. (and Apotex Corporation) H2-Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Appco Pharma
2.9.1 Appco Pharma Details
2.9.2 Appco Pharma Major Business
2.9.3 Appco Pharma H2-Receptor Antagonists Product and Services
2.9.4 Appco Pharma H2-Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Aurobindo Pharma
2.10.1 Aurobindo Pharma Details
2.10.2 Aurobindo Pharma Major Business
2.10.3 Aurobindo Pharma H2-Receptor Antagonists Product and Services
2.10.4 Aurobindo Pharma H2-Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Ben Venue Laboratories Inc.
2.11.1 Ben Venue Laboratories Inc. Details
2.11.2 Ben Venue Laboratories Inc. Major Business
2.11.3 Ben Venue Laboratories Inc. H2-Receptor Antagonists Product and Services
2.11.4 Ben Venue Laboratories Inc. H2-Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Boehringer Ingelheim
2.12.1 Boehringer Ingelheim Details
2.12.2 Boehringer Ingelheim Major Business
2.12.3 Boehringer Ingelheim H2-Receptor Antagonists Product and Services
2.12.4 Boehringer Ingelheim H2-Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 Breckenridge Pharmaceuticals
2.13.1 Breckenridge Pharmaceuticals Details
2.13.2 Breckenridge Pharmaceuticals Major Business
2.13.3 Breckenridge Pharmaceuticals H2-Receptor Antagonists Product and Services
2.13.4 Breckenridge Pharmaceuticals H2-Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.14 Contract Pharmacal Corp.
2.14.1 Contract Pharmacal Corp. Details
2.14.2 Contract Pharmacal Corp. Major Business
2.14.3 Contract Pharmacal Corp. H2-Receptor Antagonists Product and Services
2.14.4 Contract Pharmacal Corp. H2-Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.15 Dr. Reddy’s Laboratories Inc.
2.15.1 Dr. Reddy’s Laboratories Inc. Details
2.15.2 Dr. Reddy’s Laboratories Inc. Major Business
2.15.3 Dr. Reddy’s Laboratories Inc. H2-Receptor Antagonists Product and Services
2.15.4 Dr. Reddy’s Laboratories Inc. H2-Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.16 Geri-Care Pharmaceuticals
2.16.1 Geri-Care Pharmaceuticals Details
2.16.2 Geri-Care Pharmaceuticals Major Business
2.16.3 Geri-Care Pharmaceuticals H2-Receptor Antagonists Product and Services
2.16.4 Geri-Care Pharmaceuticals H2-Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.17 GlaxoSmithKline
2.17.1 GlaxoSmithKline Details
2.17.2 GlaxoSmithKline Major Business
2.17.3 GlaxoSmithKline H2-Receptor Antagonists Product and Services
2.17.4 GlaxoSmithKline H2-Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.18 Glenmark Pharmaceuticals
2.18.1 Glenmark Pharmaceuticals Details
2.18.2 Glenmark Pharmaceuticals Major Business
2.18.3 Glenmark Pharmaceuticals H2-Receptor Antagonists Product and Services
2.18.4 Glenmark Pharmaceuticals H2-Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.19 Granules Pharmaceuticals Inc.
2.19.1 Granules Pharmaceuticals Inc. Details
2.19.2 Granules Pharmaceuticals Inc. Major Business
2.19.3 Granules Pharmaceuticals Inc. H2-Receptor Antagonists Product and Services
2.19.4 Granules Pharmaceuticals Inc. H2-Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.20 Heritage Pharma Labs Inc.
2.20.1 Heritage Pharma Labs Inc. Details
2.20.2 Heritage Pharma Labs Inc. Major Business
2.20.3 Heritage Pharma Labs Inc. H2-Receptor Antagonists Product and Services
2.20.4 Heritage Pharma Labs Inc. H2-Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.21 Hikma Pharmaceuticals
2.21.1 Hikma Pharmaceuticals Details
2.21.2 Hikma Pharmaceuticals Major Business
2.21.3 Hikma Pharmaceuticals H2-Receptor Antagonists Product and Services
2.21.4 Hikma Pharmaceuticals H2-Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.22 Hi-Tech Pharmacal Co.
2.22.1 Hi-Tech Pharmacal Co. Details
2.22.2 Hi-Tech Pharmacal Co. Major Business
2.22.3 Hi-Tech Pharmacal Co. H2-Receptor Antagonists Product and Services
2.22.4 Hi-Tech Pharmacal Co. H2-Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.23 Lannett Co.
2.23.1 Lannett Co. Details
2.23.2 Lannett Co. Major Business
2.23.3 Lannett Co. H2-Receptor Antagonists Product and Services
2.23.4 Lannett Co. H2-Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.24 Mylan Pharmaceuticals Inc.
2.24.1 Mylan Pharmaceuticals Inc. Details
2.24.2 Mylan Pharmaceuticals Inc. Major Business
2.24.3 Mylan Pharmaceuticals Inc. H2-Receptor Antagonists Product and Services
2.24.4 Mylan Pharmaceuticals Inc. H2-Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.25 Nostrum Laboratories Inc.
2.25.1 Nostrum Laboratories Inc. Details
2.25.2 Nostrum Laboratories Inc. Major Business
2.25.3 Nostrum Laboratories Inc. H2-Receptor Antagonists Product and Services
2.25.4 Nostrum Laboratories Inc. H2-Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.26 Novitium Pharma
2.26.1 Novitium Pharma Details
2.26.2 Novitium Pharma Major Business
2.26.3 Novitium Pharma H2-Receptor Antagonists Product and Services
2.26.4 Novitium Pharma H2-Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.27 PAI Holdings, LLC
2.27.1 PAI Holdings, LLC Details
2.27.2 PAI Holdings, LLC Major Business
2.27.3 PAI Holdings, LLC H2-Receptor Antagonists Product and Services
2.27.4 PAI Holdings, LLC H2-Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.28 Par Pharmaceutical Inc.
2.28.1 Par Pharmaceutical Inc. Details
2.28.2 Par Pharmaceutical Inc. Major Business
2.28.3 Par Pharmaceutical Inc. H2-Receptor Antagonists Product and Services
2.28.4 Par Pharmaceutical Inc. H2-Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.29 Perrigo
2.29.1 Perrigo Details
2.29.2 Perrigo Major Business
2.29.3 Perrigo H2-Receptor Antagonists Product and Services
2.29.4 Perrigo H2-Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.30 Ranbaxy Inc.
2.30.1 Ranbaxy Inc. Details
2.30.2 Ranbaxy Inc. Major Business
2.30.3 Ranbaxy Inc. H2-Receptor Antagonists Product and Services
2.30.4 Ranbaxy Inc. H2-Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.31 Sandoz Inc.
2.31.1 Sandoz Inc. Details
2.31.2 Sandoz Inc. Major Business
2.31.3 Sandoz Inc. H2-Receptor Antagonists Product and Services
2.31.4 Sandoz Inc. H2-Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.32 Sanofi-Aventis
2.32.1 Sanofi-Aventis Details
2.32.2 Sanofi-Aventis Major Business
2.32.3 Sanofi-Aventis H2-Receptor Antagonists Product and Services
2.32.4 Sanofi-Aventis H2-Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.33 Strides
2.33.1 Strides Details
2.33.2 Strides Major Business
2.33.3 Strides H2-Receptor Antagonists Product and Services
2.33.4 Strides H2-Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.34 Sun Pharma
2.34.1 Sun Pharma Details
2.34.2 Sun Pharma Major Business
2.34.3 Sun Pharma H2-Receptor Antagonists Product and Services
2.34.4 Sun Pharma H2-Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.35 Taro Pharmaceuticals
2.35.1 Taro Pharmaceuticals Details
2.35.2 Taro Pharmaceuticals Major Business
2.35.3 Taro Pharmaceuticals H2-Receptor Antagonists Product and Services
2.35.4 Taro Pharmaceuticals H2-Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.36 Teva Pharmaceuticals
2.36.1 Teva Pharmaceuticals Details
2.36.2 Teva Pharmaceuticals Major Business
2.36.3 Teva Pharmaceuticals H2-Receptor Antagonists Product and Services
2.36.4 Teva Pharmaceuticals H2-Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.37 Thirty Madison
2.37.1 Thirty Madison Details
2.37.2 Thirty Madison Major Business
2.37.3 Thirty Madison H2-Receptor Antagonists Product and Services
2.37.4 Thirty Madison H2-Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.38 Torrent Pharma
2.38.1 Torrent Pharma Details
2.38.2 Torrent Pharma Major Business
2.38.3 Torrent Pharma H2-Receptor Antagonists Product and Services
2.38.4 Torrent Pharma H2-Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.39 Unique Pharmaceutical Laboratories
2.39.1 Unique Pharmaceutical Laboratories Details
2.39.2 Unique Pharmaceutical Laboratories Major Business
2.39.3 Unique Pharmaceutical Laboratories H2-Receptor Antagonists Product and Services
2.39.4 Unique Pharmaceutical Laboratories H2-Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.40 VKT Pharma
2.40.1 VKT Pharma Details
2.40.2 VKT Pharma Major Business
2.40.3 VKT Pharma H2-Receptor Antagonists Product and Services
2.40.4 VKT Pharma H2-Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 H2-Receptor Antagonists Sales by Manufacturer
3.1 Global H2-Receptor Antagonists Sales in Volume by Manufacturer (2019-2021e)
3.2 Global H2-Receptor Antagonists Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in H2-Receptor Antagonists
3.4 Market Concentration Rate
3.4.1 Top 3 H2-Receptor Antagonists Manufacturer Market Share
3.4.2 Top 6 H2-Receptor Antagonists Manufacturer Market Share
3.5 Global H2-Receptor Antagonists Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and H2-Receptor Antagonists Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global H2-Receptor Antagonists Market Size by Region
4.1.1 Global H2-Receptor Antagonists Sales in Volume by Region (2016-2026)
4.1.2 Global H2-Receptor Antagonists Revenue by Region (2016-2026)
4.2 North America H2-Receptor Antagonists Revenue (2016-2026)
4.3 Europe H2-Receptor Antagonists Revenue (2016-2026)
4.4 Asia-Pacific H2-Receptor Antagonists Revenue (2016-2026)
4.5 South America H2-Receptor Antagonists Revenue (2016-2026)
4.6 Middle East and Africa H2-Receptor Antagonists Revenue (2016-2026)
5 Market Segment by Type
5.1 Global H2-Receptor Antagonists Sales in Volume by Type (2016-2026)
5.2 Global H2-Receptor Antagonists Revenue by Type (2016-2026)
5.3 Global H2-Receptor Antagonists Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global H2-Receptor Antagonists Sales in Volume by Application (2016-2026)
6.2 Global H2-Receptor Antagonists Revenue by Application (2016-2026)
6.3 Global H2-Receptor Antagonists Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America H2-Receptor Antagonists Sales by Type (2016-2026)
7.2 North America H2-Receptor Antagonists Sales by Application (2016-2026)
7.3 North America H2-Receptor Antagonists Market Size by Country
7.3.1 North America H2-Receptor Antagonists Sales in Volume by Country (2016-2026)
7.3.2 North America H2-Receptor Antagonists Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe H2-Receptor Antagonists Sales by Type (2016-2026)
8.2 Europe H2-Receptor Antagonists Sales by Application (2016-2026)
8.3 Europe H2-Receptor Antagonists Market Size by Country
8.3.1 Europe H2-Receptor Antagonists Sales in Volume by Country (2016-2026)
8.3.2 Europe H2-Receptor Antagonists Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific H2-Receptor Antagonists Sales by Type (2016-2026)
9.2 Asia-Pacific H2-Receptor Antagonists Sales by Application (2016-2026)
9.3 Asia-Pacific H2-Receptor Antagonists Market Size by Region
9.3.1 Asia-Pacific H2-Receptor Antagonists Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific H2-Receptor Antagonists Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America H2-Receptor Antagonists Sales by Type (2016-2026)
10.2 South America H2-Receptor Antagonists Sales by Application (2016-2026)
10.3 South America H2-Receptor Antagonists Market Size by Country
10.3.1 South America H2-Receptor Antagonists Sales in Volume by Country (2016-2026)
10.3.2 South America H2-Receptor Antagonists Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa H2-Receptor Antagonists Sales by Type (2016-2026)
11.2 Middle East & Africa H2-Receptor Antagonists Sales by Application (2016-2026)
11.3 Middle East & Africa H2-Receptor Antagonists Market Size by Country
11.3.1 Middle East & Africa H2-Receptor Antagonists Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa H2-Receptor Antagonists Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 H2-Receptor Antagonists Typical Distributors
12.3 H2-Receptor Antagonists Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global H2-Receptor Antagonists Revenue by Type, (USD Million), 2021-2026
Table 2. Global H2-Receptor Antagonists Revenue by Application, (USD Million), 2021-2026
Table 3. Acic Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 4. Acic Pharmaceuticals Major Business
Table 5. Acic Pharmaceuticals H2-Receptor Antagonists Product and Services
Table 6. Acic Pharmaceuticals H2-Receptor Antagonists Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Actavis Mid Atlantic LLC Basic Information, Manufacturing Base and Competitors
Table 8. Actavis Mid Atlantic LLC Major Business
Table 9. Actavis Mid Atlantic LLC H2-Receptor Antagonists Product and Services
Table 10. Actavis Mid Atlantic LLC H2-Receptor Antagonists Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Ajanta Pharma Basic Information, Manufacturing Base and Competitors
Table 12. Ajanta Pharma Major Business
Table 13. Ajanta Pharma H2-Receptor Antagonists Product and Services
Table 14. Ajanta Pharma H2-Receptor Antagonists Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. AmerisourceBergen Basic Information, Manufacturing Base and Competitors
Table 16. AmerisourceBergen Major Business
Table 17. AmerisourceBergen H2-Receptor Antagonists Product and Services
Table 18. AmerisourceBergen H2-Receptor Antagonists Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Amneal Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 20. Amneal Pharmaceuticals Major Business
Table 21. Amneal Pharmaceuticals H2-Receptor Antagonists Product and Services
Table 22. Amneal Pharmaceuticals H2-Receptor Antagonists Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. ANDA Repository Basic Information, Manufacturing Base and Competitors
Table 24. ANDA Repository Major Business
Table 25. ANDA Repository H2-Receptor Antagonists Product and Services
Table 26. ANDA Repository H2-Receptor Antagonists Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Ani Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 28. Ani Pharmaceuticals Major Business
Table 29. Ani Pharmaceuticals H2-Receptor Antagonists Product and Services
Table 30. Ani Pharmaceuticals H2-Receptor Antagonists Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Apotex Inc. (and Apotex Corporation) Basic Information, Manufacturing Base and Competitors
Table 32. Apotex Inc. (and Apotex Corporation) Major Business
Table 33. Apotex Inc. (and Apotex Corporation) H2-Receptor Antagonists Product and Services
Table 34. Apotex Inc. (and Apotex Corporation) H2-Receptor Antagonists Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Appco Pharma Basic Information, Manufacturing Base and Competitors
Table 36. Appco Pharma Major Business
Table 37. Appco Pharma H2-Receptor Antagonists Product and Services
Table 38. Appco Pharma H2-Receptor Antagonists Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 40. Aurobindo Pharma Major Business
Table 41. Aurobindo Pharma H2-Receptor Antagonists Product and Services
Table 42. Aurobindo Pharma H2-Receptor Antagonists Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Ben Venue Laboratories Inc. Basic Information, Manufacturing Base and Competitors
Table 44. Ben Venue Laboratories Inc. Major Business
Table 45. Ben Venue Laboratories Inc. H2-Receptor Antagonists Product and Services
Table 46. Ben Venue Laboratories Inc. H2-Receptor Antagonists Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 48. Boehringer Ingelheim Major Business
Table 49. Boehringer Ingelheim H2-Receptor Antagonists Product and Services
Table 50. Boehringer Ingelheim H2-Receptor Antagonists Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Breckenridge Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 52. Breckenridge Pharmaceuticals Major Business
Table 53. Breckenridge Pharmaceuticals H2-Receptor Antagonists Product and Services
Table 54. Breckenridge Pharmaceuticals H2-Receptor Antagonists Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Contract Pharmacal Corp. Basic Information, Manufacturing Base and Competitors
Table 56. Contract Pharmacal Corp. Major Business
Table 57. Contract Pharmacal Corp. H2-Receptor Antagonists Product and Services
Table 58. Contract Pharmacal Corp. H2-Receptor Antagonists Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Dr. Reddy's Laboratories Inc. Basic Information, Manufacturing Base and Competitors
Table 60. Dr. Reddy's Laboratories Inc. Major Business
Table 61. Dr. Reddy's Laboratories Inc. H2-Receptor Antagonists Product and Services
Table 62. Dr. Reddy's Laboratories Inc. H2-Receptor Antagonists Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Geri-Care Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 64. Geri-Care Pharmaceuticals Major Business
Table 65. Geri-Care Pharmaceuticals H2-Receptor Antagonists Product and Services
Table 66. Geri-Care Pharmaceuticals H2-Receptor Antagonists Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 68. GlaxoSmithKline Major Business
Table 69. GlaxoSmithKline H2-Receptor Antagonists Product and Services
Table 70. GlaxoSmithKline H2-Receptor Antagonists Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 71. Glenmark Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 72. Glenmark Pharmaceuticals Major Business
Table 73. Glenmark Pharmaceuticals H2-Receptor Antagonists Product and Services
Table 74. Glenmark Pharmaceuticals H2-Receptor Antagonists Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 75. Granules Pharmaceuticals Inc. Basic Information, Manufacturing Base and Competitors
Table 76. Granules Pharmaceuticals Inc. Major Business
Table 77. Granules Pharmaceuticals Inc. H2-Receptor Antagonists Product and Services
Table 78. Granules Pharmaceuticals Inc. H2-Receptor Antagonists Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 79. Heritage Pharma Labs Inc. Basic Information, Manufacturing Base and Competitors
Table 80. Heritage Pharma Labs Inc. Major Business
Table 81. Heritage Pharma Labs Inc. H2-Receptor Antagonists Product and Services
Table 82. Heritage Pharma Labs Inc. H2-Receptor Antagonists Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 83. Hikma Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 84. Hikma Pharmaceuticals Major Business
Table 85. Hikma Pharmaceuticals H2-Receptor Antagonists Product and Services
Table 86. Hikma Pharmaceuticals H2-Receptor Antagonists Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 87. Hi-Tech Pharmacal Co. Basic Information, Manufacturing Base and Competitors
Table 88. Hi-Tech Pharmacal Co. Major Business
Table 89. Hi-Tech Pharmacal Co. H2-Receptor Antagonists Product and Services
Table 90. Hi-Tech Pharmacal Co. H2-Receptor Antagonists Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 91. Lannett Co. Basic Information, Manufacturing Base and Competitors
Table 92. Lannett Co. Major Business
Table 93. Lannett Co. H2-Receptor Antagonists Product and Services
Table 94. Lannett Co. H2-Receptor Antagonists Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 95. Mylan Pharmaceuticals Inc. Basic Information, Manufacturing Base and Competitors
Table 96. Mylan Pharmaceuticals Inc. Major Business
Table 97. Mylan Pharmaceuticals Inc. H2-Receptor Antagonists Product and Services
Table 98. Mylan Pharmaceuticals Inc. H2-Receptor Antagonists Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 99. Nostrum Laboratories Inc. Basic Information, Manufacturing Base and Competitors
Table 100. Nostrum Laboratories Inc. Major Business
Table 101. Nostrum Laboratories Inc. H2-Receptor Antagonists Product and Services
Table 102. Nostrum Laboratories Inc. H2-Receptor Antagonists Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 103. Novitium Pharma Basic Information, Manufacturing Base and Competitors
Table 104. Novitium Pharma Major Business
Table 105. Novitium Pharma H2-Receptor Antagonists Product and Services
Table 106. Novitium Pharma H2-Receptor Antagonists Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 107. PAI Holdings, LLC Basic Information, Manufacturing Base and Competitors
Table 108. PAI Holdings, LLC Major Business
Table 109. PAI Holdings, LLC H2-Receptor Antagonists Product and Services
Table 110. PAI Holdings, LLC H2-Receptor Antagonists Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 111. Par Pharmaceutical Inc. Basic Information, Manufacturing Base and Competitors
Table 112. Par Pharmaceutical Inc. Major Business
Table 113. Par Pharmaceutical Inc. H2-Receptor Antagonists Product and Services
Table 114. Par Pharmaceutical Inc. H2-Receptor Antagonists Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 115. Perrigo Basic Information, Manufacturing Base and Competitors
Table 116. PerrigoMajor Business
Table 117. Perrigo H2-Receptor Antagonists Product and Services
Table 118. Perrigo H2-Receptor Antagonists Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 119. Ranbaxy Inc. Basic Information, Manufacturing Base and Competitors
Table 120. Ranbaxy Inc. Major Business
Table 121. Ranbaxy Inc. H2-Receptor Antagonists Product and Services
Table 122. Ranbaxy Inc. H2-Receptor Antagonists Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 123. Global H2-Receptor Antagonists Sales by Manufacturer (2019-2021e) & (K Units)
Table 124. Global H2-Receptor Antagonists Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 125. Market Position of Manufacturers in H2-Receptor Antagonists, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 126. Global H2-Receptor Antagonists Production Capacity by Company, (K Units): 2020 VS 2021
Table 127. Head Office and H2-Receptor Antagonists Production Site of Key Manufacturer
Table 128. H2-Receptor Antagonists New Entrant and Capacity Expansion Plans
Table 129. H2-Receptor Antagonists Mergers & Acquisitions in the Past Five Years
Table 130. Global H2-Receptor Antagonists Sales by Region (2016-2021e) & (K Units)
Table 131. Global H2-Receptor Antagonists Sales by Region (2021-2026) & (K Units)
Table 132. Global H2-Receptor Antagonists Revenue by Region (2016-2021e) & (USD Million)
Table 133. Global H2-Receptor Antagonists Revenue by Region (2021-2026) & (USD Million)
Table 134. Global H2-Receptor Antagonists Sales by Type (2016-2021e) & (K Units)
Table 135. Global H2-Receptor Antagonists Sales by Type (2021-2026) & (K Units)
Table 136. Global H2-Receptor Antagonists Revenue by Type (2016-2021e) & (USD Million)
Table 137. Global H2-Receptor Antagonists Revenue by Type (2021-2026) & (USD Million)
Table 138. Global H2-Receptor Antagonists Price by Type (2016-2021e) & (US$/Unit)
Table 139. Global H2-Receptor Antagonists Price by Type (2021-2026) & (US$/Unit)
Table 140. Global H2-Receptor Antagonists Sales by Application (2016-2021e) & (K Units)
Table 141. Global H2-Receptor Antagonists Sales by Application (2021-2026) & (K Units)
Table 142. Global H2-Receptor Antagonists Revenue by Application (2016-2021e) & (USD Million)
Table 143. Global H2-Receptor Antagonists Revenue by Application (2021-2026) & (USD Million)
Table 144. Global H2-Receptor Antagonists Price by Application (2016-2021e) & (US$/Unit)
Table 145. Global H2-Receptor Antagonists Price by Application (2021-2026) & (US$/Unit)
Table 146. North America H2-Receptor Antagonists Sales by Country (2016-2021e) & (K Units)
Table 147. North America H2-Receptor Antagonists Sales by Country (2021-2026) & (K Units)
Table 148. North America H2-Receptor Antagonists Revenue by Country (2016-2021e) & (USD Million)
Table 149. North America H2-Receptor Antagonists Revenue by Country (2021-2026) & (USD Million)
Table 150. North America H2-Receptor Antagonists Sales by Type (2016-2021e) & (K Units)
Table 151. North America H2-Receptor Antagonists Sales by Type (2021-2026) & (K Units)
Table 152. North America H2-Receptor Antagonists Sales by Application (2016-2021e) & (K Units)
Table 153. North America H2-Receptor Antagonists Sales by Application (2021-2026) & (K Units)
Table 154. Europe H2-Receptor Antagonists Sales by Country (2016-2021e) & (K Units)
Table 155. Europe H2-Receptor Antagonists Sales by Country (2021-2026) & (K Units)
Table 156. Europe H2-Receptor Antagonists Revenue by Country (2016-2021e) & (USD Million)
Table 157. Europe H2-Receptor Antagonists Revenue by Country (2021-2026) & (USD Million)
Table 158. Europe H2-Receptor Antagonists Sales by Type (2016-2021e) & (K Units)
Table 159. Europe H2-Receptor Antagonists Sales by Type (2021-2026) & (K Units)
Table 160. Europe H2-Receptor Antagonists Sales by Application (2016-2021e) & (K Units)
Table 161. Europe H2-Receptor Antagonists Sales by Application (2021-2026) & (K Units)
Table 162. Asia-Pacific H2-Receptor Antagonists Sales by Region (2016-2021e) & (K Units)
Table 163. Asia-Pacific H2-Receptor Antagonists Sales by Region (2021-2026) & (K Units)
Table 164. Asia-Pacific H2-Receptor Antagonists Revenue by Region (2016-2021e) & (USD Million)
Table 165. Asia-Pacific H2-Receptor Antagonists Revenue by Region (2021-2026) & (USD Million)
Table 166. Asia-Pacific H2-Receptor Antagonists Sales by Type (2016-2021e) & (K Units)
Table 167. Asia-Pacific H2-Receptor Antagonists Sales by Type (2021-2026) & (K Units)
Table 168. Asia-Pacific H2-Receptor Antagonists Sales by Application (2016-2021e) & (K Units)
Table 169. Asia-Pacific H2-Receptor Antagonists Sales by Application (2021-2026) & (K Units)
Table 170. South America H2-Receptor Antagonists Sales by Country (2016-2021e) & (K Units)
Table 171. South America H2-Receptor Antagonists Sales by Country (2021-2026) & (K Units)
Table 172. South America H2-Receptor Antagonists Revenue by Country (2016-2021e) & (USD Million)
Table 173. South America H2-Receptor Antagonists Revenue by Country (2021-2026) & (USD Million)
Table 174. South America H2-Receptor Antagonists Sales by Type (2016-2021e) & (K Units)
Table 175. South America H2-Receptor Antagonists Sales by Type (2021-2026) & (K Units)
Table 176. South America H2-Receptor Antagonists Sales by Application (2016-2021e) & (K Units)
Table 177. South America H2-Receptor Antagonists Sales by Application (2021-2026) & (K Units)
Table 178. Middle East & Africa H2-Receptor Antagonists Sales by Country (2016-2021e) & (K Units)
Table 179. Middle East & Africa H2-Receptor Antagonists Sales by Country (2021-2026) & (K Units)
Table 180. Middle East & Africa H2-Receptor Antagonists Revenue by Country (2016-2021e) & (USD Million)
Table 181. Middle East & Africa H2-Receptor Antagonists Revenue by Country (2021-2026) & (USD Million)
Table 182. Middle East & Africa H2-Receptor Antagonists Sales by Type (2016-2021e) & (K Units)
Table 183. Middle East & Africa H2-Receptor Antagonists Sales by Type (2021-2026) & (K Units)
Table 184. Middle East & Africa H2-Receptor Antagonists Sales by Application (2016-2021e) & (K Units)
Table 185. Middle East & Africa H2-Receptor Antagonists Sales by Application (2021-2026) & (K Units)
Table 186. Direct Channel Pros & Cons
Table 187. Indirect Channel Pros & Cons
Table 188. H2-Receptor Antagonists Typical Distributors
Table 189. H2-Receptor Antagonists Typical Customers
List of Figures
Figure 1. H2-Receptor Antagonists Picture
Figure 2. Global H2-Receptor Antagonists Sales Market Share by Type in 2020
Figure 3. Ranitidine/Zantac
Figure 4. Cimetidine
Figure 5. Famotidine
Figure 6. Nazatidine
Figure 7. Global H2-Receptor Antagonists Sales Market Share by Application in 2020
Figure 8. Retail Stores
Figure 9. Clinics
Figure 10. Hospitals
Figure 11. OTC Sales
Figure 12. Global H2-Receptor Antagonists Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 13. Global H2-Receptor Antagonists Market Size and Forecast (2016-2026) & (USD Million)
Figure 14. Global H2-Receptor Antagonists Sales (2016-2026) & (K Units)
Figure 15. Global H2-Receptor Antagonists Price by Type (2016-2026) & (US$/Unit)
Figure 16. Global H2-Receptor Antagonists Production Capacity (2016-2026) & (K Units)
Figure 17. Global H2-Receptor Antagonists Production Capacity by Geographic Region: 2020 VS 2021
Figure 18. H2-Receptor Antagonists Market Drivers
Figure 19. H2-Receptor Antagonists Market Restraints
Figure 20. H2-Receptor Antagonists Market Trends
Figure 21. Global H2-Receptor Antagonists Sales Market Share by Manufacturer in 2020
Figure 22. Global H2-Receptor Antagonists Revenue Market Share by Manufacturer in 2020
Figure 23. H2-Receptor Antagonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 24. Top 3 H2-Receptor Antagonists Manufacturer (Revenue) Market Share in 2020
Figure 25. Top 6 H2-Receptor Antagonists Manufacturer (Revenue) Market Share in 2020
Figure 26. Global H2-Receptor Antagonists Sales Market Share by Region (2016-2026)
Figure 27. Global H2-Receptor Antagonists Revenue Market Share by Region (2016-2026)
Figure 28. North America H2-Receptor Antagonists Revenue (2016-2026) & (USD Million)
Figure 29. Europe H2-Receptor Antagonists Revenue (2016-2026) & (USD Million)
Figure 30. Asia-Pacific H2-Receptor Antagonists Revenue (2016-2026) & (USD Million)
Figure 31. South America H2-Receptor Antagonists Revenue (2016-2026) & (USD Million)
Figure 32. Middle East & Africa H2-Receptor Antagonists Revenue (2016-2026) & (USD Million)
Figure 33. Global H2-Receptor Antagonists Sales Market Share by Type (2016-2026)
Figure 34. Global H2-Receptor Antagonists Revenue Market Share by Type (2016-2026)
Figure 35. Global H2-Receptor Antagonists Price by Type (2016-2026) & (US$/Unit)
Figure 36. Global H2-Receptor Antagonists Sales Market Share by Application (2016-2026)
Figure 37. Global H2-Receptor Antagonists Revenue Market Share by Application (2016-2026)
Figure 38. Global H2-Receptor Antagonists Price by Application (2016-2026) & (US$/Unit)
Figure 39. North America H2-Receptor Antagonists Sales Market Share by Type (2016-2026)
Figure 40. North America H2-Receptor Antagonists Sales Market Share by Application (2016-2026)
Figure 41. North America H2-Receptor Antagonists Sales Market Share by Country (2016-2026)
Figure 42. North America H2-Receptor Antagonists Revenue Market Share by Country (2016-2026)
Figure 43. United States H2-Receptor Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Canada H2-Receptor Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Mexico H2-Receptor Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Europe H2-Receptor Antagonists Sales Market Share by Type (2016-2026)
Figure 47. Europe H2-Receptor Antagonists Sales Market Share by Application (2016-2026)
Figure 48. Europe H2-Receptor Antagonists Sales Market Share by Country (2016-2026)
Figure 49. Europe H2-Receptor Antagonists Revenue Market Share by Country (2016-2026)
Figure 50. Germany H2-Receptor Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. France H2-Receptor Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. United Kingdom H2-Receptor Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Russia H2-Receptor Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Italy H2-Receptor Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Asia-Pacific H2-Receptor Antagonists Sales Market Share by Region (2016-2026)
Figure 56. Asia-Pacific H2-Receptor Antagonists Sales Market Share by Application (2016-2026)
Figure 57. Asia-Pacific H2-Receptor Antagonists Sales Market Share by Region (2016-2026)
Figure 58. Asia-Pacific H2-Receptor Antagonists Revenue Market Share by Region (2016-2026)
Figure 59. China H2-Receptor Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Japan H2-Receptor Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Korea H2-Receptor Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. India H2-Receptor Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Southeast Asia H2-Receptor Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Australia H2-Receptor Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South America H2-Receptor Antagonists Sales Market Share by Type (2016-2026)
Figure 66. South America H2-Receptor Antagonists Sales Market Share by Application (2016-2026)
Figure 67. South America H2-Receptor Antagonists Sales Market Share by Country (2016-2026)
Figure 68. South America H2-Receptor Antagonists Revenue Market Share by Country (2016-2026)
Figure 69. Brazil H2-Receptor Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Argentina H2-Receptor Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Middle East & Africa H2-Receptor Antagonists Sales Market Share by Type (2016-2026)
Figure 72. Middle East & Africa H2-Receptor Antagonists Sales Market Share by Application (2016-2026)
Figure 73. Middle East & Africa H2-Receptor Antagonists Sales Market Share by Country (2016-2026)
Figure 74. Middle East & Africa H2-Receptor Antagonists Revenue Market Share by Country (2016-2026)
Figure 75. Turkey H2-Receptor Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Egypt H2-Receptor Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Saudi Arabia H2-Receptor Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. South Africa H2-Receptor Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source

以下、関連資料のご紹介
  • モメタゾンのグローバル市場 2021年：企業別、地域別、種類・用途別
    Global Mometasone Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
    GIR-203B16240 2021年12月 100Pages
    モメタゾン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
  • グリコピロニウムのグローバル市場 2021年：企業別、地域別、種類・用途別
    Global Glycopyrronium Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
    GIR-203B16193 2021年12月 103Pages
    グリコピロニウム市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。<...
  • アゼラスチン薬のグローバル市場 2021年：企業別、地域別、種類・用途別
    Global Azelastine Drug Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
    GIR-203B16046 2021年12月 96Pages
    アゼラスチン薬市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
  • カルシトリオールカプセルのグローバル市場 2021年：企業別、地域別、種類・用途別
    Global Calcitriol Capsules Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
    GIR-203B16083 2021年12月 93Pages
    カルシトリオールカプセル市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供し...
  • 半固形剤フォームのグローバル市場 2021年：企業別、地域別、種類・用途別
    Global Semisolid Dosage Form Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
    GIR-203B04036 2021年12月 122Pages
    半固形剤フォーム市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。<...
  • 医薬品＆化粧品のグローバル市場 2021年：企業別、地域別、種類・用途別
    Global Pharma & Cosmetics Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
    GIR-203B16293 2021年12月 107Pages
    医薬品＆化粧品市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
  • 製薬用アルギニンのグローバル市場 2021年：企業別、地域別、種類・用途別
    Global Pharma Grade Arginine Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
    GIR-203B03331 2021年12月 96Pages
    製薬用アルギニン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。<...
  • 重度アレルギー治療用注射のグローバル市場 2021年：企業別、地域別、種類・用途別
    Global Severe Allergy Treatment Injection Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
    GIR-203B16344 2021年12月 106Pages
    重度アレルギー治療用注射市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供し...
  • ジフルプレドナート眼科用乳剤のグローバル市場 2021年：企業別、地域別、種類・用途別
    Global Difluprednate Ophthalmic Emulsion Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
    GIR-203B16132 2021年12月 93Pages
    ジフルプレドナート眼科用乳剤市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提...
  • エピネフリン塩酸塩注射のグローバル市場 2021年：企業別、地域別、種類・用途別
    Global Epinephrine Hydrochlaride Injection Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
    GIR-203B16152 2021年12月 104Pages
    エピネフリン塩酸塩注射市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供しま...